TCL Archive Major Decisions On How NCI Will Spend Extra Money Won’t Be Made for Three-Four Months November 4, 1983
TCL Archive Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer August 27, 2010
TCL Archive House Committee Probes NCI $5.2 Billion Sole-Source Contract With SAIC-Frederick. November 14, 2008